POLYNEURON

Switzerland
Breíl, Grisons, Switzerland, CH-4057

Company profile

POLYNEURON company profile

Polyneuron is a developer of novel therapeutics intended to facilitate the treatment of antibody-mediated autoimmune diseases. The company's biodegradable glycopolymers-based therapeutics selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact, enabling medical practitioners to treat patients with immune disorders in a safe and effective manner.

Business identity

Contact email
[email protected]
Phone number
+41788371011
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2014-01-01, Year

Headquarters

Postal code
CH-4057
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
10
Total equity funding
$44.3M
Last funding
Series A / $15.4M / 2020-09-16
Last equity funding
Series A / $15.4M
Investors
9
Lead investors
4
Founders
2
Articles
10

Founders and investors

Founders

Pascal HaenggiRuben Herrendorff

Lead investors

EVA BaselNew Enterprise AssociatesSofinnova PartnersVenture Kick

Investors

HBM Healthcare InvestmentsNew Enterprise AssociatesSofinnova PartnersVenture KickZürcher Kantonal Bank